Investing Profile

Vincent Brichard

Investor

Senior Vice-president at GlaxoSmithKline Biologicals

Brussels

‌

Your Intro Paths to Vincent Brichard

‌

Find Vincent Brichard on

Current Investing Position

Investor

Investment Range

$1M - $5.0M

Sweet Spot

$1.5M

Investments On Record

Vincent Brichard is on these Sector & Stage Rankings

Vincent Brichard's Investments On Record (5)

Company	StageDateRound Size	Total Raised
ATB Therapeutics	Series ANov 2024$57M	$57M
Co-investors: John de Koning (EQT Life Sciences)
Minervax	Series UnknownOct 2023$57M	$140M
Co-investors: Kabeer Aziz (Adjuvant Capital), Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures)
ImCheck Therapeutics	Series CJun 2022$100M Series BDec 2019$53M	$180M
Co-investors: Klaus Breiner (Pureos Bioventures), Rémi Droller (Kurma Partners), Michael Baran (Pfizer Venture Investments), Dr. Regina Hodits (Wellington Partners), Raphael Wisniewski (Andera Partners), Florent Gros (Earlybird Venture Capital)
Egle Therapeutics	Series AOct 2021$47M	$47M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Jacques Mizrahi (Bioqube Ventures)
FoRx Therapeutics	SeedApr 2020$11M	$11M
Co-investors: Denis Patrick (Pfizer Venture Investments), Florian Müllershausen (Novartis Venture Fund), Therese Liechtenstein (M Ventures (Merck)), Vincent Ossipow (Omega Funds)